BenzingaOctober 22, 2026 at 9:45 AM NY5 Days Ago
Morgan Stanley Maintains Equal-Weight on Elevance Health, Raises Price Target to $449
Morgan Stanley analyst Erin Wright maintains Elevance Health (NYSE:ELV) with a Equal-Weight and raises the price target from $404 to $449.
What This Story Means
Claude is explaining the story in plain words…
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: Benzinga
